1. Home
  2. GAIA vs ACET Comparison

GAIA vs ACET Comparison

Compare GAIA & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gaia Inc.

GAIA

Gaia Inc.

HOLD

Current Price

$2.49

Market Cap

70.9M

ML Signal

HOLD

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$8.22

Market Cap

77.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GAIA
ACET
Founded
1988
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.9M
77.3M
IPO Year
1999
2017

Fundamental Metrics

Financial Performance
Metric
GAIA
ACET
Price
$2.49
$8.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$6.50
$48.33
AVG Volume (30 Days)
73.6K
85.7K
Earning Date
05-04-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
18.18
N/A
EPS
N/A
N/A
Revenue
$4,500,000.00
N/A
Revenue This Year
$13.07
N/A
Revenue Next Year
$12.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.50
N/A
52 Week Low
$2.30
$0.46
52 Week High
$6.39
$9.05

Technical Indicators

Market Signals
Indicator
GAIA
ACET
Relative Strength Index (RSI) 43.43 55.45
Support Level $2.37 $7.50
Resistance Level $3.41 $8.68
Average True Range (ATR) 0.19 0.54
MACD -0.01 -0.06
Stochastic Oscillator 23.94 64.64

Price Performance

Historical Comparison
GAIA
ACET

About GAIA Gaia Inc.

Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. The company operates in a single reporting segment. Its revenues is derived from subscription fees for services related to streaming content to the members. Geographically, it derives a majority of its revenue from the United States and also has an International presence.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).

Share on Social Networks: